Additive and Antagonistic Effects Among Combination of Agonists of Peroxisome Proliferator-Activated Receptor gamma (PPARg) on Transcriptional Activity
Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 2
Abstract
Objective: The Angiotensin-II receptor blocker telmisartan and sulfonylurea glimepiride may have clinical usefulness as partial agonists of PPARg. We investigated additive and antagonistic effects among combinations of telmisartan, glimepiride, and the Thiazolidinedione (TZD) selective PPARg agonist pioglitazone on transcriptional activity of PPARg. Materials/Methods: The receptors of pCMX-PPARg and pCMX-RXR, and PPRE-Luc reporter gene were transfected into CV1 cells, and treated with following agents, and luciferace assay was performed. Moreover, mammalian two-hybrid assay was done using GAL4 responsive reporter tk-MH100(UAS)×4-Luc and the chimeric receptor GAL4-PPARg. Results: Telmisartan increased transactivation of PPARg dose dependently. Activation by telmisartan 10 µM was 58.8% of that by pioglitazone 10 µM. Glimepiride also increased transactivation of PPARg dose dependently. Activation by glimepiride 10 µM was 49.8% of that by pioglitazone 10 µM. Addition of telmisartan 5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Moreover, addition of pioglitazone 0.5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Mammalian two-hybrid assay showed additive effect between glimepiride and telmisartan on binding of SRC-1 to PPARg. On the other hand, addition of glimepiride 10 and 50 µM reduced transactivation by pioglitazone 5 µM to 74% and 70%, respectively. Conclusion: Partial agonists of PPARg additively enhanced transactivation by other agonists, whereas high concentration of partial agonists reduced transactivation by full agonist antagonistically.
Authors and Affiliations
Daisuke Tsuriya
Keywords
Related Articles
- EP ID EP550007
- DOI 10.17140/DROJ-1-105
- Views 155
- Downloads 0
Effect of Low Carbohydrate Diet on Type 2 Diabetic Patients and Usefulness of M-Value
Background: Debate between the Calorie Restriction (CR) and Low-Carbohydrate Diet (LCD) has been continued for several years. We have started LCD therapy for diabetic patients since 1999, and experienced good response to...
Regulatory T-Cells in Treatment of Type-1 Diabetes: Types and Approaches
Regulatory T-cells (Tregs) play important role in regulation of immune responses to self-antigens. Alterations in frequency and function of Tregs have been reported in Type 1 Diabetes (T1D) subjects. Tregs have the poten...
Wellness Fasting and Hyperketosis
Ketoacidosis is sometimes a lethal complication of diabetes mellitus.1-3 Ketone bodies are considered to be the toxic elements of ketoacidosis. Wilder3 considered that the threshold of ketogenesis (i.e. the maximal rati...
Ocular Health Screening in a Type 1 Diabetes Mellitus Population
Background: Type 1 Diabetes Mellitus is among the most common conditions worldwide, affecting nearly 95 million children worldwide. One of the detrimental effects of this condition can be vision loss. Comprehensive annua...
Ketone Body Production and Excretion During Wellness Fasting
Introduction: The importance of ketone body metabolism in diabetic patients has been known since the 1970s, but recently β-hydroxybutyrate (βHB) has been identified as a key component of a metabolic signaling pathway. Ho...